Timothy M. Chapman

3.5k total citations
23 papers, 1.0k citations indexed

About

Timothy M. Chapman is a scholar working on Molecular Biology, Organic Chemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Timothy M. Chapman has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Timothy M. Chapman's work include Malaria Research and Control (4 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Biochemical and Molecular Research (3 papers). Timothy M. Chapman is often cited by papers focused on Malaria Research and Control (4 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Biochemical and Molecular Research (3 papers). Timothy M. Chapman collaborates with scholars based in United Kingdom, United States and New Zealand. Timothy M. Chapman's co-authors include Benjamin G. Davis, Michael J. Burt, B. A. Chapman, Chris Frampton, Judith A Collett, Fréderic Ménard, Mark Lautens, T A Walmsley, Peter M. George and Chris Dockendorff and has published in prestigious journals such as Journal of the American Chemical Society, Gut and Food Chemistry.

In The Last Decade

Timothy M. Chapman

23 papers receiving 1.0k citations

Peers

Countries citing papers authored by Timothy M. Chapman

Since Specialization

Citations

This map shows the geographic impact of Timothy M. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy M. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy M. Chapman more than expected).

Fields of papers citing papers by Timothy M. Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy M. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy M. Chapman. The network helps show where Timothy M. Chapman may publish in the future.

Co-authorship network of co-authors of Timothy M. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy M. Chapman. A scholar is included among the top collaborators of Timothy M. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy M. Chapman. Timothy M. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists 2021 ·European Journal of Medicinal Chemistry ·(unknown), Almudena Ortega‐Gómez, Sanne L. Maas, José Garrido‐Mesa, Bartolo Ferraro, Mauro Perretti, Andy Merritt, Gerry A. F. Nicolaes, Oliver Soehnlein, Timothy M. Chapman	4
2	Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation 2021 ·European Journal of Medicinal Chemistry ·(unknown), Almudena Ortega‐Gómez, Sanne L. Maas, Mauro Perretti, Andy Merritt, Oliver Soehnlein, Timothy M. Chapman	9
3	Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential 2021 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Eoin Brennan, Catherine Godson, Timothy M. Chapman	46
4	Design, Synthesis, and Testing of Potent, Selective Hepsin Inhibitors via Application of an Automated Closed-Loop Optimization Platform 2018 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Bimbisar Desai, Manoj K. Ramjee, (unknown), Gary J. Tarver, Adrian G. Wright, Kristian Birchall, Timothy M. Chapman, Topi A. Tervonen, Juha Klefström	29
5	N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1–XPF 2015 ·Bioorganic & Medicinal Chemistry Letters ·Timothy M. Chapman, Claire Wallace, (unknown), Preeti Bakrania, (unknown), P.J. Coombs, (unknown), (unknown), Janet Brownlees, David W. Melton, Barbara Saxty	19
6	Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF 2015 ·Bioorganic & Medicinal Chemistry Letters ·Timothy M. Chapman, (unknown), Claire Wallace, (unknown), Preeti Bakrania, (unknown), P.J. Coombs, (unknown), (unknown), (unknown), Janet Brownlees, David W. Melton, Barbara Saxty	26
7	Optimization of an Imidazopyridazine Series of Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 (PfCDPK1) 2014 ·Journal of Medicinal Chemistry ·Timothy M. Chapman, Simon A. Osborne, Claire Wallace, Kristian Birchall, Nathalie Bouloc, (unknown), Keith H. Ansell, Debra L. Taylor, Barbara Clough, Judith L. Green, Anthony A. Holder	42
8	Substituted imidazopyridazines are potent and selective inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) 2013 ·Bioorganic & Medicinal Chemistry Letters ·Timothy M. Chapman, Simon A. Osborne, Nathalie Bouloc, Jonathan M. Large, Claire Wallace, Kristian Birchall, Keith H. Ansell, (unknown), Debra L. Taylor, Barbara Clough, Judith L. Green, Anthony A. Holder	43
9	Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis 2012 ·Bioorganic & Medicinal Chemistry Letters ·Timothy M. Chapman, Nathalie Bouloc, Roger S. Buxton, (unknown), Kathryn Lougheed, Simon A. Osborne, Barbara Saxty, Stephen J. Smerdon, Debra L. Taylor, David Whalley	42
10	Ligand-Controlled Selectivity in the Desymmetrization of meso Cyclopenten-1,4-diols via Rhodium(I)-Catalyzed Addition of Arylboronic Acids 2010 ·The Journal of Organic Chemistry ·Fréderic Ménard, David Pérez, Daniela Sustac Roman, Timothy M. Chapman, Mark Lautens	36
11	Prooxidant Activity of Oxidized α‐Tocopherol in Vegetable Oils 2009 ·Journal of Food Science ·Timothy M. Chapman, Hyun Jung Kim, David B. Min	18
12	Antioxidant mechanisms of Trolox and ascorbic acid on the oxidation of riboflavin in milk under light 2009 ·Food Chemistry ·(unknown), Timothy M. Chapman, Hyun Jung Kim, David B. Min	33
13	Rhodium‐Catalyzed Asymmetric Allylic Substitution with Boronic Acid Nucleophiles. 2007 ·ChemInform ·Fréderic Ménard, Timothy M. Chapman, Chris Dockendorff, Mark Lautens	2
14	Rhodium-Catalyzed Asymmetric Allylic Substitution with Boronic Acid Nucleophiles 2006 ·Organic Letters ·Fréderic Ménard, Timothy M. Chapman, Chris Dockendorff, Mark Lautens	73
15	Glyco- and Peptidomimetics from Three-Component Joullié−Ugi Coupling Show Selective Antiviral Activity 2004 ·Journal of the American Chemical Society ·Timothy M. Chapman, (unknown), Baohua Gu, Timothy M. Block, D. I. C. SCOPES, (unknown), Stephen M. Courtney, Luke A. McNeill, Christopher J. Schofield, Benjamin G. Davis	71
16	Highly Diastereoselective Additions to Polyhydroxylated Pyrrolidine Cyclic Imines: Ready Elaboration of Aza‐Sugar Scaffolds To Create Diverse Carbohydrate‐Processing Enzyme Probes 2003 ·Chemistry - A European Journal ·Timothy M. Chapman, (unknown), (unknown), Benjamin G. Davis	75
17	Novel Cyclic Sugar Imines: Carbohydrate Mimics and Easily Elaborated Scaffolds for Aza-Sugars 2001 ·Organic Letters ·Benjamin G. Davis, (unknown), Timothy M. Chapman, (unknown), (unknown)	64
18	Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies. 1999 ·PubMed ·Judith A Collett, Michael J. Burt, Chris Frampton, (unknown), Timothy M. Chapman, (unknown), H. Bramwell Cook, B. A. Chapman	38
19	The significance of haemochromatosis gene mutations in the general population: implications for screening 1998 ·Gut ·Michael J. Burt, Peter M. George, (unknown), Judith A Collett, Chris Frampton, Timothy M. Chapman, T A Walmsley, B. A. Chapman	186
20	Gallbladder Volume (Comparison of Diabetics and Controls) 1998 ·Digestive Diseases and Sciences ·B. A. Chapman, Timothy M. Chapman, Christopher Frampton, (unknown), Richard B. Allan, Ian Wilson, Michael J. Burt	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact